BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Job Trends

  Layoffs Ahead As Johnson & Johnson Retools Diabetes Unit

  November 14, 2013

   · 

  1 min read
• Deals

  Tandem Diabetes Care Raises $120 Million In Upsized IPO

  November 14, 2013

   · 

  1 min read
• Business

  Cook Medical Names New President, But Hawkins Isn’t Going Anywhere

  November 14, 2013

   · 

  1 min read
• Genetown

  Broad Institute Launches Next Decade With New $100 Million Gift

  November 14, 2013

   · 

  5 min read
• Drug Development

  Theravance, Inc. Abandons ADHD Drug After Drug Fails Phase 2 Study

  November 14, 2013

   · 

  1 min read
• BioCapital

  Novartis AG and Novavax, Inc.'s Experimental Bird Flu Vaccines Show Promise In Early Trials

  November 14, 2013

   · 

  1 min read
• Deals

  Rumor Mill: Is Volcano Corporation Ripe For A Buyout?

  November 14, 2013

   · 

  1 min read
• FDA

  Bruin Biometrics Awarded CE Mark For The SEM Scanner, An Innovative Diagnostic Tool To Detect Pressure Induced Tissue Damage

  November 14, 2013

   · 

  1 min read
• Business

  Antares Pharma, Inc. Enters Into An Exclusive U.S. Promotion And Marketing Agreement With LEO Pharma For OTREXUP™ In Dermatology

  November 14, 2013

   · 

  1 min read
• Drug Development

  ACADIA Pharmaceuticals, Inc.s Announces Initiation Of Phase 2 Trial With Pimavanserin For Alzheimer’s Disease Psychosis

  November 14, 2013

   · 

  1 min read